Artwork

Content provided by Stan Berteloot. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stan Berteloot or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Intermountain Health's AI Initiative and Regeneron's $100M Bet: Advancements in Health IT and Biomedicine

4:35
 
Share
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on June 08, 2024 07:55 (1M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 414692355 series 3564236
Content provided by Stan Berteloot. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stan Berteloot or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
"AI in Life Sciences" dives into the world where technology and biology intersect, providing expert insight and analysis on the latest trends, breakthroughs, and controversies. In this episode, we explore a potential bird flu threat in Midwestern milk, the innovative use of AI in tackling workforce shortages in healthcare, and impressive revenue growth in AstraZeneca, thanks in part to their cancer drugs. We also discuss Regeneron Pharmaceuticals’ $100M wager on Mammoth’s CRISPR technology, the crucial role of AI understanding for health IT leaders, and how AI is revolutionizing drug discovery at AION Labs. Finally, we delve into Bristol Myers Squibb’s major restructuring and its implications for employees and the company's future growth. Stay tuned for these stories and more on "AI in Life Sciences".
  continue reading

17 episodes

Artwork
iconShare
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on June 08, 2024 07:55 (1M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 414692355 series 3564236
Content provided by Stan Berteloot. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stan Berteloot or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
"AI in Life Sciences" dives into the world where technology and biology intersect, providing expert insight and analysis on the latest trends, breakthroughs, and controversies. In this episode, we explore a potential bird flu threat in Midwestern milk, the innovative use of AI in tackling workforce shortages in healthcare, and impressive revenue growth in AstraZeneca, thanks in part to their cancer drugs. We also discuss Regeneron Pharmaceuticals’ $100M wager on Mammoth’s CRISPR technology, the crucial role of AI understanding for health IT leaders, and how AI is revolutionizing drug discovery at AION Labs. Finally, we delve into Bristol Myers Squibb’s major restructuring and its implications for employees and the company's future growth. Stay tuned for these stories and more on "AI in Life Sciences".
  continue reading

17 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide